Recent early clinical drug development for acute kidney injury. (2017)

First Author: Gallagher KM
Attributed to:  MICA: RIP1 kinase inhibition to reduce kidney injury funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1080/13543784.2017.1274730

PubMed Identifier: 27997816

Publication URI: http://europepmc.org/abstract/MED/27997816

Type: Journal Article/Review

Volume: 26

Parent Publication: Expert opinion on investigational drugs

Issue: 2

ISSN: 1354-3784